直肠癌新辅助放疗研究进展
《现代肿瘤医学》[ISSN:1672-4992/CN:61-1415/R]
- 期数:
- 2022年19期
- 页码:
- 3614-3617
- 栏目:
- 综述
- 出版日期:
- 2022-08-30
文章信息/Info
- Title:
- Advances in neoadjuvant radiotherapy for rectal cancer
- Author(s):
- ZHAO Yaru; QIAO Wenbo
- Harbin Medical University Cancer Hospital,Heilongjiang Harbin 150081,China.
- Keywords:
- rectal cancer; neoadjuvant radiotherapy; radiotherapy technology; radiotherapy adverse reactions; observation and waiting
- 分类号:
- R735.3+7
- DOI:
- 10.3969/j.issn.1672-4992.2022.19.035
- 文献标识码:
- A
- 摘要:
- 在过去的近40年里，直肠癌的治疗方案逐渐标准化。大多数早期直肠癌患者仅通过手术即可得到充分的治疗。然而，相当比例的直肠癌患者处于局部进展期，此类患者需要行新辅助治疗。直肠癌的新辅助放射治疗已被证明能有效地降低患者术前肿瘤分期、改善患者生存以及降低直肠癌局部复发率等，随之而来的是患者放疗后出现的不同程度的放疗不良反应，但随着放射治疗规范化、放射治疗技术及设备的改进，放疗不良反应严重程度在逐渐降低。本文就新辅助放疗中的放疗方案的选择、放射治疗技术、放疗不良反应、放疗后的手术时间以及放疗后的观察与等待等问题的最新研究进展进行了系统性的综述，从而为临床直肠癌新辅助治疗提供有力依据。
- Abstract:
- In the past 40 years,the treatment of rectal cancer has been gradually standardized.Most patients with early rectal cancer can get adequate treatment only through surgery.However,a considerable proportion of patients with rectal cancer are in local progression,and such patients need neoadjuvant therapy.Neoadjuvant radiotherapy for rectal cancer has been proved to be effective in reducing the preoperative tumor staging,improving the survival of patients and reducing the local recurrence rate of rectal cancer,followed by different degrees of adverse reactions after radiotherapy.However,with the standardization of radiotherapy and the improvement of radiotherapy technology and equipment,the severity of adverse reactions is gradually decreasing.In this paper,the latest research progress of neoadjuvant radiotherapy in the selection of radiotherapy scheme,radiotherapy technology,adverse reactions of radiotherapy,operation time after radiotherapy and observation and waiting after radiotherapy were systematically reviewed,so as to provide a strong basis for clinical neoadjuvant treatment of rectal cancer.
参考文献/References
[1]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2018［J］.CA Cancer J Clin,2018,68(1):7-30.
[2] 郭天安，谢丽，赵江，等.中国结直肠癌1988—2009年发病率和死亡率趋势分析［J］.中华胃肠外科杂志,2018,21(01):33-40.
GUO TA,XIE L,ZHAO J,et al.Trend analysis of morbidity and mortality of colorectal cancer in China from 1988 to 2009［J］.Chinese Journal of Gastrointestinal Surgery,2018,21(01):33-40.
[3] 孙可欣，郑荣寿，张思维，等.2015年中国分地区恶性肿瘤发病和死亡分析［J］.中国肿瘤,2019,28(01):1-11.
ZHANG KX,ZHENG RS,ZHANG SW,et al.Report of cancer epidemiology in China,2015［J］.Chinese Journal of Oncology,2019,28(01):1-11.
[4] GLYNNE-JONES R,WYRWICZ L,TIRET E,et al.Rectal cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up［J］.Ann Oncol,2018,29(Suppl 4):v263.
[5] COUWENBERG AM,BURBACH JPM,VAN GREVENSTEIN WMU,et al.Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis［J］.Clin Colorectal Cancer,2018,17(3):e499-e512.
[6] 胡方杰，崔滨滨.直肠癌经新辅助治疗后达到临床完全缓解的评估策略及观察和等待策略［J］.现代肿瘤医学,2018,26(14):2309-2314.
HU FH,CUI BB.The evaluation strategy and WAW strategy of rectal cancer with a cCR after neoadjuvant treatment［J］.Modern Oncology,2018,26(14):2309-2314.
[7] YU Y,LI Y,XU C,et al.Comparison of long course and short course preoperative radiotherapy in the treatment of locally advanced rectal cancer:a systematic review and meta-analysis［J］.Rev Esp Enferm Dig,2019,111(1):17-27.
[8] WAWOK P,POLKOWSKI W,RICHTER P,et al.Preoperative radiotherapy and local excision of rectal cancer:Long-term results of a randomised study［J］.Radiother Oncol,2018,127(3):396-403.
[9] SEBAG-MONTEFIORE D,STEPHENS RJ,STEELE R,et al.Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer(MRC CR07 and NCIC-CTG C016):a multicentre,randomised trial［J］.Lancet,2009,373(9666):811-820.
[10] WANG X,ZHENG B,LU X,et al.Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer:Meta-analysis with trial sequential analysis of long-term survival data［J］.PLoS One,2018,13(7):e200142.
[11] MA B,GAO P,SONG Y,et al.Short-course radiotherapy in neoadjuvant treatment for rectal cancer:A systematic review and Meta-analysis［J］.Clin Colorectal Cancer,2018,17(4):320-330.
[12] BUCHWALD ZS,WYNNE J,NASTI TH,et al.Radiation,immune checkpoint blockade and the abscopal effect:A critical review on timing,dose and fractionation［J］.Front Oncol,2018,8:612.
[13] WEGNER RE,ABEL S,WHITE RJ,et al.Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting:a National Cancer Database analysis［J］.Radiat Oncol J,2018,36(4):276-284.
[14] LI CC,LIANG JA,CHUNG CY,et al.Effectiveness of intensity-modulated radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy:A population-based propensity score-matched analysis［J］.Anticancer Res,2019,39(3):1479-1484.
[15] WEE CW,KANG HC,WU HG,et al.Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation:a meta-analysis and pooled-analysis of acute toxicity［J］.Jpn J Clin Oncol,2018,48(5):458-466.
[16] LEE CY,CHANG CC,YANG HY,et al.Intensity modulated radiotherapy delivers competitive local control rate with limited acute toxicity in the adjuvant treatment of rectal cancer［J］.Jpn J Clin Oncol,2018,48(7):653-660.
[17] APPELT AL,BENTZEN SM,JAKOBSEN A,et al.Dose-response of acute urinary toxicity of long-course preoperative chemoradiotherapy for rectal cancer［J］.Acta Oncol,2015,54(2):179-186.
[18] DAPPER H,OECHSNER M,MUNCH S,et al.Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer［J］.Radiat Oncol,2018,13(1):169.
[19] INTVEN MPW,DE MOL VAN OTTERLOO SR,MOOK S,et al.Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac:clinical implementation and initial experience［J］.Radiother Oncol,2020,154:172-178.
[20] JEANS EB,JETHWA KR,HARMSEN WS,et al.Clinical implementation of preoperative short-course pencil beam scanning proton therapy for patients with rectal cancer［J］.Adv Radiat Oncol,2020,5(5):865-870.
[21] FEENEY G,SEHGAL R,SHEEHAN M,et al.Neoadjuvant radiotherapy for rectal cancer management［J］.World J Gastroenterol,2019,25(33):4850-4869.
[22] BUCHLI C,MARTLING A,ABANI MA,et al.Risk of acute testicular failure after preoperative radiotherapy for rectal cancer:A prospective cohort study［J］.Ann Surg,2018,267(2):326-331.
[23] 殷麟，陈凡，冯瑞兴，等.直肠癌术前放疗VMAT与IMRT剂量学参数及急性不良反应分析［J］.现代肿瘤医学,2019,27(21):3865-3868.
YIN L,CHEN F,FENG RX,et al.Comparison of the dosimetry and the acute adverse reactions of same period chemotherapy of VMAT and IMRT preoperative radiotherapy for rectal cancer［J］.Modern Oncology,2019,27(21):3865-3868.
[24] 季力强，楼征，张卫.放射治疗导致直肠癌患者肛门括约肌功能不全的机制探讨［J］.中华胃肠外科杂志,2020,23(08):807-809.
JI LQ,LOU Z,ZHANG W.Discussion on the mechanism of anal sphincter insufficiency caused by radiotherapy in patients with rectal cancer［J］.Chinese Journal of Gastrointestinal Surgery,2020,23(08):807-809.
[25] DAPPER H,RODRIGUEZ I,MUNCH S,et al.Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer［J］.Radiat Oncol,2018,13(1):237.
[26] 谭兴颖，唐翠萍，陈杜可，等.局部晚期直肠癌术前新辅助治疗的研究进展［J］.现代肿瘤医学,2019,27(05):892-895.
TAN XY,TANG CP,CHEN DK,et al.The progress of preoperative neoadjuvant treatment of locally advanced rectal cancer［J］.Modern Oncology,2019,27(05):892-895.
[27] PETRELLI F,SGROI G,SARTI E,et al.Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer:A Meta-analysis of published studies［J］.Ann Surg,2016,263(3):458-464.
[28] 赫捷，李进，马军.中国临床肿瘤学会（CSCO）常见恶性肿瘤诊疗指南2020［M］.北京:人民卫生出版社,2020:233-242.
HE J,LI J,MA J.The Chinese society of Clinical Oncology(CSCO):guidelines for diagnosis and treatment of common malignant tumors 2020［M］.Beijing:People's Health Publishing House,2020:233-242.
[29] WU H,FANG C,HUANG L,et al.Short-course radiotherapy with immediate or delayed surgery in rectal cancer:A meta-analysis［J］.Int J Surg,2018,56:195-202.
[30] HUANG YJ,TAI C,KANG YN,et al.Early versus delayed surgery after short-course radiotherapy for rectal cancer:A network meta-analysis of randomized controlled trials［J］.Asian J Surg,2020,43(8):810-818.
[31] ERLANDSSON J,PETTERSSON D,GLINELIUS B,et al.Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy［J］.Br J Surg,2019,106(9):1248-1256.
[32] LORIMER PD,MOTZ BM,KIRKS RC,et al.Pathologic complete response rates after neoadjuvant treatment in rectal cancer:An analysis of the national cancer database［J］.Ann Surg Oncol,2017,24(8):2095-2103.
[33] HABR-GAMA A,DE SOUZA PM,RIBEIRO U,et al.Low rectal cancer:impact of radiation and chemotherapy on surgical treatment［J］.Dis Colon Rectum,1998,41(9):1087-1096.
备注/Memo
- 备注/Memo:
- 海燕科研基金（编号：JJZD2016-04）
